TY - JOUR
T1 - Cross reactivity between many anti-human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma model
AU - Kroczynska, Barbara
AU - Carbone, Michele
PY - 2006/7
Y1 - 2006/7
N2 - The aim of this study was to test the possibility of using human antibodies to study the pathogenic mechanism of SV40 and asbestos in a hamster mesothelioma model. The cellular lysates from human and hamster primary mesothelial cells were tested by Western blot analysis. All of the antibodies we tested (HGF, Notch, VEGF, Sp1, p53, PP2A, p-ERK1, p-c-jun, Fra1, Fra2, MMP1, MMP9, NFκB p65, IκB, GAPDH) cross-reacted with their hamster counterparts. These data indicate that hamster mesothelioma model and more in general hamster experimental model, can be used for functional studies because many mouse, rabbit, and goat monoclonal antibodies prepared against human antigens cross-react with their hamster counterparts.
AB - The aim of this study was to test the possibility of using human antibodies to study the pathogenic mechanism of SV40 and asbestos in a hamster mesothelioma model. The cellular lysates from human and hamster primary mesothelial cells were tested by Western blot analysis. All of the antibodies we tested (HGF, Notch, VEGF, Sp1, p53, PP2A, p-ERK1, p-c-jun, Fra1, Fra2, MMP1, MMP9, NFκB p65, IκB, GAPDH) cross-reacted with their hamster counterparts. These data indicate that hamster mesothelioma model and more in general hamster experimental model, can be used for functional studies because many mouse, rabbit, and goat monoclonal antibodies prepared against human antigens cross-react with their hamster counterparts.
KW - Asbestos
KW - Mesothelial cells
KW - Mesothelioma
KW - SV40
UR - http://www.scopus.com/inward/record.url?scp=33745700271&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745700271&partnerID=8YFLogxK
U2 - 10.1002/mc.20200
DO - 10.1002/mc.20200
M3 - Article
C2 - 16649249
AN - SCOPUS:33745700271
SN - 0899-1987
VL - 45
SP - 537
EP - 542
JO - Molecular Carcinogenesis
JF - Molecular Carcinogenesis
IS - 7
ER -